✦ LIBER ✦

Leukocyte migration inhibition test in patients with trophoblastic tumors

✍ Scribed by V. L. Kovaleva; T. A. Drozhzhina

Publisher: Springer US
Year: 1978
Tongue: English
Weight: 334 KB
Volume: 85
Category: Article
ISSN: 0007-4888
DOI: 10.1007/bf00806393

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Leukocyte migration inhibition assay of

Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma

✍ Ernesto S. Rivera; Evan M. Hersh; James M. Bowen; J. W. Barnett; Taylor Wharton; 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 761 KB

Study of trophoblastic β-globulin in the

Study of trophoblastic β-globulin in the leukocyte adhesion inhibition test during pregnancy

✍ T. M. Tsagaraeva; D. D. Petrunin; Yu. S. Tatarinov 📂 Article 📅 1981 🏛 Springer US 🌐 English ⚖ 177 KB

Migration inhibition test in lung cancer

Migration inhibition test in lung cancer patients

✍ Dr. Patrick C. Marabella; Linda L. Elias; Hiroshi Takita; Jun Minowada 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

The peripheral blood leukocyte migration

The peripheral blood leukocyte migration inhibition test in systemic lupus erythematosus

✍ T. G. Trayanova; I. T. Rass; N. N. Prozorovskaya 📂 Article 📅 1973 🏛 Springer US 🌐 English ⚖ 211 KB

Cellular immunity in patients with color

Cellular immunity in patients with colorectal adenocarcinoma measured by autologous leukocyte migration inhibition

✍ E. George Elias; Linda L. Elias; Mukund S. Didolkar; J. Richard Hebel 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB

Indirect leukocyte migration assay in pa

Indirect leukocyte migration assay in patients with malignant melanoma

✍ Lindsay J. Morrison; Alistair J. Cochran; Rona M. Mackie; Catherine E. Ross; Gay 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 French ⚖ 588 KB

## Abstract Leukocytes from 72 melanoma patients and 75 control donors were examined in a two‐stage (indirect) leukocyte migration assay, using formalin‐fixed melanoma cells (FMC) and control, normal or non‐melanoma tumour cells (FCC) as the source of antigen. Inhibitory supernatants were produced